首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

全球基因組學市場：按產品、按產品類型、按技術、按最終用戶、按服務類型、按應用、按研究類型、按地區 - 預測到 2029 年

市場調查報告書

商品編碼

1593552

全球基因組學市場：按產品、按產品類型、按技術、按最終用戶、按服務類型、按應用、按研究類型、按地區 - 預測到 2029 年

Genomics Market by Product (Kits, Consumables, Instruments), Services (Bioinformatics), Technology (Sequencing, PCR, ISH), Study Type (Epigenomics, Functional Genomics), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029

出版日期: 2024年11月13日 | 出版商:

MarketsandMarkets | 英文 563 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

基因組學市場規模預計將從 2024 年的 426.4 億美元增至 2029 年的 668.5 億美元，預測期內複合年成長率為 9.4%。

調查範圍
調查年份	2022-2029
基準年	2023年
預測期	2024-2029
考慮單位	金額（百萬美元）
按細分市場	按提供、按產品類型、按技術、按最終用戶、按服務類型、按應用、按研究類型、按地區
目標區域	北美、歐洲、亞太地區、拉丁美洲、中東/非洲

基因組學市場的成長主要是由基因組研究（包括人類微生物組）的擴展、低收入和中等收入國家對基因組舉措的更多關注以及個性化藥物的更多採用等因素推動的。然而，對安裝設備初始成本的擔憂正在影響基因組學市場的成長。

2023年，基因組學市場細分為試劑/試劑套件/消耗品、儀器和生物資訊工具。試劑、套件和消耗品是產品佔有率最大的細分市場。試劑、套件和消耗品領域在基因組學市場的產品類型類別中佔據主導地位。試劑、套件和耗材幾乎是每個基因組工作流程（從 DNA/RNA 提取、擴增、序列測定到分析）都是必不可少的，因此幾乎是研究或臨床應用所涉及的每個過程所必需的。因此，診斷、個人化醫療和藥物開發領域進行的基因組實驗數量不斷增加，推動了需求。所有這些工作流程都需要不斷補充高品質的試劑和套件，以確保準確可靠的基因組資料產生。此外，NGS 和 PCR 等最尖端科技的快速採用正在加速對專用試劑和耗材的需求。包括醫療保健、研究和生物技術在內的基因組學領域的穩定成長進一步增強了耗材領域實現的收益量，並維持了其市場領先地位。

基因組學產品市場分為醫院、診所和診斷實驗室、學術和研究機構、製藥和生物技術公司、CRO 和其他最終用戶。到2023年，醫院、診所和診斷實驗室將成為最終用戶領域中佔有率最大的細分市場。由於公民科學計劃使資料收集民主化並加速罕見疾病和個人化醫療的發現，患者更多地參與基因組研究，因此醫院、診所和診斷實驗室佔有很大佔有率。然而，製藥和生物技術公司在該領域佔據第二大佔有率。

本報告研究了全球基因組學市場，包括我總結的產品、產品類型、技術、最終用戶、服務類型、應用、研究類型、地區和參與市場的公司概況的趨勢。

介紹
市場動態
影響客戶業務的趨勢/干擾
監管狀況
價值鏈分析
技術分析
價格分析
專利分析
供應鏈分析
生態系分析
2024-2025年重大會議和活動
波特五力分析
主要相關人員和採購標準
投資金籌措場景
案例研究分析
貿易分析
人工智慧對基因組學市場的影響

第6章基因組學市場，依產品分類

介紹
產品
服務

第7章基因體學市場，依產品類型

介紹
試劑、套件及耗材
裝置
生物資訊學工具

第8章基因組產品市場（依技術）

介紹
定序
PCR
基因編輯
流式細胞技術
微陣列
原位雜合反應
其他

第9章基因組產品市場，依最終用戶分類

介紹
醫院、診斷實驗室、診所
學術研究所
製藥和生物技術公司
CRO
其他

第 10 章基因組學市場（依服務類型）

介紹
基因組分析與定序服務
樣品製備及文庫製備服務
生物資訊服務

第11章基因組學市場，按應用

介紹
藥物發現與開發
診斷
其他

第12章基因組學市場，依研究類型

介紹
功能基因體學
生物標記藥物發現
途徑分析
表觀基因
其他

第 13 章基因組服務市場（依最終使用者）

介紹
醫院、診斷實驗室、診所
學術研究所
製藥和生物技術公司
其他

第 14 章基因組學市場（按地區）

介紹
北美洲
歐洲
亞太地區
拉丁美洲
中東
非洲

第15章競爭格局

介紹
主要參與企業採用的策略/秘密
市場佔有率分析
品牌/產品比較分析
企業評估矩陣：主要參與企業，2023
企業評估矩陣：Start-Ups/小型企業，2023 年
基因組學供應商評估和財務指標
競爭場景

第16章公司簡介

主要參與企業
- ILLUMINA, INC.
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD.
- DANAHER CORPORATION
- QIAGEN
- AGILENT TECHNOLOGIES, INC.
- REVVITY
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- IQVIA INC.
- CHARLES RIVER LABORATORIES
- BIO-RAD LABORATORIES, INC.
- EUROFINS SCIENTIFIC
- PACBIO
- OXFORD NANOPORE TECHNOLOGIES PLC.
- TAKARA BIO INC.
- BGI GROUP
- EPPENDORF SE
- MERCK KGAA
- BD
- ABBOTT
- 10X GENOMICS
- NEW ENGLAND BIOLABS
- PROMEGA CORPORATION
其他公司
- CREATIVE BIOGENE
- NOVOGENE CO., LTD.
- HELIX, INC.
- PHALANX BIOTECH GROUP
- POLARIS GENOMICS

第17章附錄

簡介目錄圖表

Product Code: BT 2209

The genomics market is expected to reach USD 66.85 billion in 2029 from USD 42.64 billion in 2024, at a CAGR of 9.4% during the forecast period.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Million)
Segments	By Offerings, Products by Type, Services by Type, Products by End User
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Growth in the genomics market is mainly driven by factors like expanding genomic studies to include the human microbiome, increasing focus on genomics initiatives in low- and middle-income countries, and increased adoption of personalized medicines. However, the initial cost concern to set up the equipment is impacting the growth of the genomics market.

"The reagents, kits, and consumables segment accounted for the largest share by products segment in the genomics market in 2023"

The genomics market is segmented into reagents, kits, and consumables, instruments, and bioinformatics tools in 2023. The reagents, kits, and consumables is the segment with the largest share in products. The reagents, kits, and consumables segment dominates the product type category of the genomics market. They are crucial for almost all genomic workflows, starting from DNA/RNA extraction, amplification, and sequencing up to analysis, and therefore, are needed for nearly all processes involved in either research or clinical applications. Demand is thus triggered by the ever-growing number of genomic experiments conducted in diagnostics, personalized medicine, and drug development. Every one of these workflows demands a constant replenishment of high-quality reagents and kits to make genomic data generation accurate and reliable. Also, the rapid adoption of state-of-the-art technologies such as NGS and PCR accelerates the demand for application-specific reagents and consumables. The steady growth experienced in genomics areas such as healthcare, research, and biotechnology further builds upon the revenue volume realized on the consumable end and maintains its market top-line position..

"The academic & research institutes segment accounted for the largest share by products end-user segment in the genomics market in 2023"

The genomics product market is segmented into hospitals, clinics & diagnostics laboratories, academic & research institutes, pharmaceutical & biotechnologies companies, CROs, and other end users. The hospitals, clinics & diagnostics laboratories are the segment with the largest share in the end-user segment in 2023. The large share of hospitals, clinics & diagnostics laboratories is due to the increased patient engagement in genomic research through citizen science initiatives to democratize data collection and accelerate the discoveries in rare diseases and personalized medicine. However, the pharmaceutical & biotechnological companies accounted for the second largest share in the segment.

"The Asia Pacific region is growing at the highest CAGR in the genomics market from 2024 to 2029."

The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the large scale of population genomics projects, and the rising demand for precision medicines is supporting the growth. Further, the rising prevalence of rare and genetic diseases is attributed to the aging population of countries such as Japan, and China. This is supporting the adoption of genomics technologies in healthcare management and treatment driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

Illumina, Inc. (US)
Thermo Fisher Scientific Inc. (US)
F. Hoffmann-LA Roche Ltd. (Switzerland)
Danaher Corporation (US)
QIAGEN (Germany)
Agilent Technologies, Inc. (US)
Revvity (US)
Laboratory Corporation of America Holdings (US)
IQVIA Inc. (US)
Charles River Laboratories (US)
Bio-Rad Laboratories, Inc. (US)
Eurofins Scientific (Luxembourg)
PacBio (US)
Oxford Nanopore Technologies plc. (UK)
Takara Bio Inc. (Japan)
BGI Group (China)
Eppendorf SE (Germany)
Merck KGaA (Germany)
BD (US)
Abbott (US)
10X Genomics (US)
New England Biolabs (US)
Promega Corporation (US)
Creative Biogene (US)
Novogene Co., Ltd. (China)
Helix, Inc. (US)
Phalanx Biotech Group (US)
Polaris Genomics (US)

Research Coverage:

This research report categorizes the genomics market by offerings (products and services), products by type (reagents, kits and consumables, instruments, bioinformatics tools), products by technology (sequencing, PCR, gene editing, flow cytometry, microarrays, in situ hybridization, and other technologies), products by end user (hospitals, diagnostic laboratories, and clinics, academic and research institutes, pharmaceutical and biotechnology companies, CROs, and other end users), services by type (genomics profiling and sequencing services, sample preparation and library preparation service, bioinformatics service), application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), diagnostic applications (oncology, infectious disease, reproductive health, and other diagnostic applications), study type (functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types) end user by services (hospitals and clinics, academic & research institutes, pharmaceutical & biotechnology companies and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the genomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the genomics market. Competitive analysis of top players and upcoming startups in the genomics market ecosystem is covered in this report

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing government funding for genomics projects, Increasing prevalence of viral and inherited disorders, Advancement in NGS platforms, Growing applications of genomics), restraints (High investment costs), opportunities (Increasing use of genomics in precision medicine, Technological advancements in genomics), and challenges (Handling of large volume of data sets and their analysis, Clinical utility of genomics) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched products/services of the genomics market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the genomics market
Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-LA Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), IQVIA Inc. (US), Charles River Laboratories (US), Bio-Rad Laboratories, Inc. (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Eppendorf SE (Germany), Merck KGaA (Germany), BD (US), Abbott (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Creative Biogene (US), Novogene Co., Ltd. (China), Helix, Inc. (US), Phalanx Biotech Group (US), Polaris Genomics (US) and among others in the market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 IMPACT OF AI/GENERATIVE AI

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 MARKET SIZE ESTIMATION
- 2.2.2 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 GENOMICS MARKET OVERVIEW
4.2 ASIA PACIFIC: GENOMICS MARKET, BY OFFERING
4.3 GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 GENOMICS MARKET SHARE, BY PRODUCT END USER, 2023

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing government funding for genomics projects
  - 5.2.1.2 Increasing prevalence of viral and inherited disorders
  - 5.2.1.3 Advancements in NGS platforms
  - 5.2.1.4 Growing applications of genomics
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High investment costs
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Increasing use of genomics in precision medicine
  - 5.2.3.2 Technological advancements in genomics
- 5.2.4 CHALLENGES
  - 5.2.4.1 Handling of large volumes of data sets and their analysis
  - 5.2.4.2 Clinical utility of genomics
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 REGULATORY LANDSCAPE
- 5.4.1 REGULATORY SCENARIO
- 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5 VALUE CHAIN ANALYSIS
5.6 TECHNOLOGICAL ANALYSIS
- 5.6.1 KEY TECHNOLOGIES
  - 5.6.1.1 Sequencing by synthesis
  - 5.6.1.2 Single-molecule real-time sequencing
  - 5.6.1.3 Nanopore sequencing
  - 5.6.1.4 qPCR
  - 5.6.1.5 dPCR
  - 5.6.1.6 Microarray technology
- 5.6.2 COMPLEMENTARY TECHNOLOGIES
  - 5.6.2.1 Cytogenetics
  - 5.6.2.2 Synthetic biology
  - 5.6.2.3 Multiomics
  - 5.6.2.4 Single-cell analysis
- 5.6.3 ADJACENT TECHNOLOGIES
  - 5.6.3.1 Sample preparation technologies
  - 5.6.3.2 Data analysis
  - 5.6.3.3 Bioinformatics and computational biology
  - 5.6.3.4 Artificial intelligence and machine learning
5.7 PRICING ANALYSIS
- 5.7.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY OFFERING
  - 5.7.1.1 Average selling price of key players, by instrument
  - 5.7.1.2 Average selling price of key players, by consumable
  - 5.7.1.3 Average selling price of key players, by service
- 5.7.2 AVERAGE SELLING PRICE, BY REGION
5.8 PATENT ANALYSIS
5.9 SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS
5.11 KEY CONFERENCES AND EVENTS, 2024-2025
5.12 PORTER'S FIVE FORCES ANALYSIS
- 5.12.1 PORTER'S FIVE FORCES ANALYSIS
- 5.12.2 INTENSITY OF COMPETITIVE RIVALRY
- 5.12.3 BARGAINING POWER OF SUPPLIERS
- 5.12.4 BARGAINING POWER OF BUYERS
- 5.12.5 THREAT OF SUBSTITUTES
- 5.12.6 THREAT OF NEW ENTRANTS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 KEY BUYING CRITERIA, BY END USER
5.14 INVESTMENT AND FUNDING SCENARIO
5.15 CASE STUDY ANALYSIS
5.16 TRADE ANALYSIS
- 5.16.1 IMPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), 2017-2021
- 5.16.2 EXPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), 2017-2021
- 5.16.3 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022-2023
- 5.16.4 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022-2023
5.17 IMPACT OF AI ON GENOMICS MARKET

6 GENOMICS MARKET, BY OFFERING

6.1 INTRODUCTION
6.2 PRODUCTS
6.3 SERVICES

7 GENOMICS MARKET, BY PRODUCT TYPE

7.1 INTRODUCTION
7.2 REAGENTS, KITS, AND CONSUMABLES
- 7.2.1 LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR CONSUMABLES, KITS, AND REAGENTS
7.3 INSTRUMENTS
- 7.3.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
7.4 BIOINFORMATICS TOOLS
- 7.4.1 BIOINFORMATICS TOOLS TO HELP TURN RAW DATA INTO MEANINGFUL INSIGHTS

8 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY

8.1 INTRODUCTION
8.2 SEQUENCING
- 8.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH
8.3 PCR
- 8.3.1 RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH
8.4 GENE EDITING
- 8.4.1 RISING DEMAND FOR NEWER THERAPEUTIC APPROACH DRIVING GROWTH
8.5 FLOW CYTOMETRY
- 8.5.1 RISING DEMAND FOR FLOW CYTOMETRY FOR AGRIGENOMICS TO DRIVE MARKET GROWTH
8.6 MICROARRAYS
- 8.6.1 RISING ADOPTION OF HIGH THROUGHPUT TECHNOLOGIES LIMITING MARKET GROWTH
8.7 IN SITU HYBRIDIZATION
- 8.7.1 INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS DRIVING GROWTH OF SEGMENT
8.8 OTHER TECHNOLOGIES

9 GENOMICS PRODUCTS MARKET, BY END USER

9.1 INTRODUCTION
9.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
- 9.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
9.3 ACADEMIC AND RESEARCH INSTITUTES
- 9.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- 9.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS IS DRIVING GROWTH
9.5 CROS
- 9.5.1 RISING COLLABORATION BETWEEN PHARMA COMPANIES AND CROS DRIVING MARKET GROWTH
9.6 OTHER END USERS

10 GENOMICS MARKET, BY SERVICE TYPE

10.1 INTRODUCTION
10.2 GENOMIC PROFILING AND SEQUENCING SERVICES
- 10.2.1 INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH
10.3 SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES
- 10.3.1 INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH
10.4 BIOINFORMATICS SERVICES
- 10.4.1 RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH

11 GENOMICS MARKET, BY APPLICATION

11.1 INTRODUCTION
11.2 DRUG DISCOVERY AND DEVELOPMENT
- 11.2.1 DRUG DISCOVERY AND DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET
11.3 DIAGNOSTICS
- 11.3.1 RISING DEMAND DUE TO CLINICAL GENOMICS TO SUPPORT MARKET GROWTH
  - 11.3.1.1 Oncology
    - 11.3.1.1.1 Rising demand for targeted therapies to drive market growth
- 11.3.2 INFECTIOUS DISEASES
  - 11.3.2.1 Rising demand for comprehensive genomic data in clinical genomics to drive market growth
- 11.3.3 REPRODUCTIVE HEALTH
  - 11.3.3.1 Rising focus on genetic diseases to drive market growth
- 11.3.4 OTHER DIAGNOSTIC APPLICATIONS
  - 11.3.4.1 Rising demand for comprehensive genomic data in clinical genomics to drive market growth
- 11.3.5 AGRICULTURE AND ANIMAL RESEARCH
  - 11.3.5.1 Genomics to help improve crop productivity
11.4 OTHER APPLICATIONS

12 GENOMICS MARKET, BY STUDY TYPE

12.1 INTRODUCTION
12.2 FUNCTIONAL GENOMICS
- 12.2.1 INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES TO DRIVE MARKET GROWTH
12.3 BIOMARKER DISCOVERY
- 12.3.1 RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
12.4 PATHWAY ANALYSIS
- 12.4.1 RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH
12.5 EPIGENOMICS
- 12.5.1 RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH
12.6 OTHER STUDY TYPES

13 GENOMICS SERVICES MARKET, BY END USER

13.1 INTRODUCTION
13.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
- 13.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
13.3 ACADEMIC AND RESEARCH INSTITUTES
- 13.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
13.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- 13.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH
13.5 OTHER END USERS

14 GENOMICS MARKET, BY REGION

14.1 INTRODUCTION
14.2 NORTH AMERICA
- 14.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
- 14.2.2 US
  - 14.2.2.1 US expected to dominate market in North America
- 14.2.3 CANADA
  - 14.2.3.1 Increasing government initiatives in genomics research to boost market growth
14.3 EUROPE
- 14.3.1 EUROPE: MACROECONOMIC OUTLOOK
- 14.3.2 GERMANY
  - 14.3.2.1 Germany to dominate European genomics market
- 14.3.3 UK
  - 14.3.3.1 Strategic initiatives and funding for genomics research to support market growth
- 14.3.4 FRANCE
  - 14.3.4.1 Increasing government investment in genomics research to drive growth
- 14.3.5 ITALY
  - 14.3.5.1 Favorable funding scenario to drive adoption of advanced sequencing technology
- 14.3.6 SPAIN
  - 14.3.6.1 Growing focus on advancements in personalized medicine to support market growth
- 14.3.7 REST OF EUROPE
14.4 ASIA PACIFIC
- 14.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
- 14.4.2 CHINA
  - 14.4.2.1 China to dominate Asia Pacific market during forecast period
- 14.4.3 JAPAN
  - 14.4.3.1 Rising number of collaborations in genomics to drive market
- 14.4.4 INDIA
  - 14.4.4.1 Government and private initiatives for genomics to propel market
- 14.4.5 AUSTRALIA
  - 14.4.5.1 Increased genomics research in Australia to support market growth
- 14.4.6 SOUTH KOREA
  - 14.4.6.1 Demand for advanced sequencing technologies to support market growth in South Korea
- 14.4.7 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
- 14.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
- 14.5.2 BRAZIL
  - 14.5.2.1 Increased government investments in genomics advancements to drive market in Brazil
- 14.5.3 MEXICO
  - 14.5.3.1 Rising demand for chronic disease treatment to support market growth in Mexico
- 14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST
- 14.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
- 14.6.2 GCC COUNTRIES
  - 14.6.2.1 Saudi Arabia
    - 14.6.2.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth
  - 14.6.2.2 United Arab Emirates
    - 14.6.2.2.1 Growing collaborations to advance genome sequencing to aid market growth in UAE
  - 14.6.2.3 Rest of GCC Countries
- 14.6.3 REST OF MIDDLE EAST
14.7 AFRICA
- 14.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA
- 14.7.2 AFRICA: MACROECONOMIC OUTLOOK

15 COMPETITIVE LANDSCAPE

15.1 INTRODUCTION
15.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
15.3 REVENUE ANALYSIS
15.4 MARKET SHARE ANALYSIS
15.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
- 15.5.1 ILLUMINA, INC.
- 15.5.2 THERMO FISHER SCIENTIFIC INC.
- 15.5.3 DANAHER CORPORATION
- 15.5.4 ROCHE
- 15.5.5 QIAGEN
15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 15.6.1 STARS
- 15.6.2 EMERGING LEADERS
- 15.6.3 PERVASIVE PLAYERS
- 15.6.4 PARTICIPANTS
- 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 15.7.1 PROGRESSIVE COMPANIES
- 15.7.2 RESPONSIVE COMPANIES
- 15.7.3 DYNAMIC COMPANIES
- 15.7.4 STARTING BLOCKS
- 15.7.5 COMPETITIVE BENCHMARKING
15.8 VALUATION AND FINANCIAL METRICS OF GENOMICS VENDORS
15.9 COMPETITIVE SCENARIO
- 15.9.1 DEALS
- 15.9.2 EXPANSIONS

16 COMPANY PROFILES

16.1 KEY PLAYERS
- 16.1.1 ILLUMINA, INC.
  - 16.1.1.1 Business overview
  - 16.1.1.2 Products/Services offered
  - 16.1.1.3 Recent developments
    - 16.1.1.3.1 Product launches
    - 16.1.1.3.2 Deals
    - 16.1.1.3.3 Expansions
  - 16.1.1.4 MnM view
    - 16.1.1.4.1 Key strengths
    - 16.1.1.4.2 Strategic choices
    - 16.1.1.4.3 Weaknesses and competitive threats
- 16.1.2 THERMO FISHER SCIENTIFIC INC.
  - 16.1.2.1 Business overview
  - 16.1.2.2 Products/Services offered
  - 16.1.2.3 Recent developments
    - 16.1.2.3.1 Product launches
    - 16.1.2.3.2 Deals
    - 16.1.2.3.3 Expansions
  - 16.1.2.4 MnM view
    - 16.1.2.4.1 Key strengths
    - 16.1.2.4.2 Strategic choices
    - 16.1.2.4.3 Weaknesses and competitive threats
- 16.1.3 F. HOFFMANN-LA ROCHE LTD.
  - 16.1.3.1 Business overview
  - 16.1.3.2 Products/Services offered
    - 16.1.3.2.1 Product launches
    - 16.1.3.2.2 Deals
  - 16.1.3.3 MnM view
    - 16.1.3.3.1 Key strengths
    - 16.1.3.3.2 Strategic choices
    - 16.1.3.3.3 Weaknesses and competitive threats
- 16.1.4 DANAHER CORPORATION
  - 16.1.4.1 Business overview
  - 16.1.4.2 Products/Services offered
    - 16.1.4.2.1 Product launches
    - 16.1.4.2.2 Deals
    - 16.1.4.2.3 Expansions
- 16.1.5 QIAGEN
  - 16.1.5.1 Business overview
  - 16.1.5.2 Products/Services offered
  - 16.1.5.3 Recent developments
    - 16.1.5.3.1 Deals
    - 16.1.5.3.2 Expansions
- 16.1.6 AGILENT TECHNOLOGIES, INC.
  - 16.1.6.1 Business overview
  - 16.1.6.2 Products/Services offered
  - 16.1.6.3 Recent developments
    - 16.1.6.3.1 Deals
    - 16.1.6.3.2 Expansions
- 16.1.7 REVVITY
  - 16.1.7.1 Business overview
  - 16.1.7.2 Products/Services offered
  - 16.1.7.3 Recent developments
    - 16.1.7.3.1 Product launches
    - 16.1.7.3.2 Deals
    - 16.1.7.3.3 Expansions
- 16.1.8 LABORATORY CORPORATION OF AMERICA HOLDINGS
  - 16.1.8.1 Business overview
  - 16.1.8.2 Services offered
  - 16.1.8.3 Recent developments
    - 16.1.8.3.1 Service launches
    - 16.1.8.3.2 Deals
- 16.1.9 IQVIA INC.
  - 16.1.9.1 Business overview
  - 16.1.9.2 Services offered
  - 16.1.9.3 Recent developments
    - 16.1.9.3.1 Deals
    - 16.1.9.3.2 Expansions
- 16.1.10 CHARLES RIVER LABORATORIES
  - 16.1.10.1 Business overview
  - 16.1.10.2 Services offered
  - 16.1.10.3 Recent developments
    - 16.1.10.3.1 Deals
- 16.1.11 BIO-RAD LABORATORIES, INC.
  - 16.1.11.1 Business overview
  - 16.1.11.2 Products/Services offered
  - 16.1.11.3 Recent developments
    - 16.1.11.3.1 Product launches
    - 16.1.11.3.2 Deals
- 16.1.12 EUROFINS SCIENTIFIC
  - 16.1.12.1 Business overview
  - 16.1.12.2 Products/Services offered
  - 16.1.12.3 Recent developments
    - 16.1.12.3.1 Product launches
    - 16.1.12.3.2 Deals
- 16.1.13 PACBIO
  - 16.1.13.1 Business overview
  - 16.1.13.2 Products/Services offered
  - 16.1.13.3 Recent developments
    - 16.1.13.3.1 Product & service launches
    - 16.1.13.3.2 Deals
    - 16.1.13.3.3 Expansions
    - 16.1.13.3.4 Other developments
- 16.1.14 OXFORD NANOPORE TECHNOLOGIES PLC.
  - 16.1.14.1 Business overview
  - 16.1.14.2 Products/Services offered
  - 16.1.14.3 Recent developments
    - 16.1.14.3.1 Product & service launches
    - 16.1.14.3.2 Deals
- 16.1.15 TAKARA BIO INC.
  - 16.1.15.1 Business overview
  - 16.1.15.2 Products/Services offered
  - 16.1.15.3 Recent developments
    - 16.1.15.3.1 Product & service launches
    - 16.1.15.3.2 Deals
- 16.1.16 BGI GROUP
  - 16.1.16.1 Business overview
  - 16.1.16.2 Products/Services offered
  - 16.1.16.3 Recent developments
    - 16.1.16.3.1 Product & service launches
    - 16.1.16.3.2 Deals
    - 16.1.16.3.3 Other developments
- 16.1.17 EPPENDORF SE
  - 16.1.17.1 Business overview
  - 16.1.17.2 Products/Services offered
  - 16.1.17.3 Recent developments
    - 16.1.17.3.1 Product & service launches
- 16.1.18 MERCK KGAA
  - 16.1.18.1 Business overview
  - 16.1.18.2 Products/Services offered
  - 16.1.18.3 Recent developments
    - 16.1.18.3.1 Expansions
- 16.1.19 BD
  - 16.1.19.1 Business overview
  - 16.1.19.2 Products/Services offered
  - 16.1.19.3 Recent developments
    - 16.1.19.3.1 Product & service launches
    - 16.1.19.3.2 Deals
- 16.1.20 ABBOTT
  - 16.1.20.1 Business overview
  - 16.1.20.2 Products/Services offered
  - 16.1.20.3 Recent developments
    - 16.1.20.3.1 Product & service launches
- 16.1.21 10X GENOMICS
  - 16.1.21.1 Business overview
  - 16.1.21.2 Products/Services offered
  - 16.1.21.3 Recent developments
    - 16.1.21.3.1 Product launches
- 16.1.22 NEW ENGLAND BIOLABS
  - 16.1.22.1 Business overview
  - 16.1.22.2 Products/Services offered
  - 16.1.22.3 Recent developments
    - 16.1.22.3.1 Product & service launches
    - 16.1.22.3.2 Deals
- 16.1.23 PROMEGA CORPORATION
  - 16.1.23.1 Business overview
  - 16.1.23.2 Products/Services offered
  - 16.1.23.3 Recent developments
    - 16.1.23.3.1 Product & service launches
    - 16.1.23.3.2 Other developments
16.2 OTHER PLAYERS
- 16.2.1 CREATIVE BIOGENE
- 16.2.2 NOVOGENE CO., LTD.
- 16.2.3 HELIX, INC.
- 16.2.4 PHALANX BIOTECH GROUP
- 16.2.5 POLARIS GENOMICS

17 APPENDIX

17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS

簡介目錄圖表

List of Tables

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 3 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD)
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021-2023 (USD)
TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD)
TABLE 12 INDICATIVE PRICE TREND, BY REGION, 2021-2023 (USD)
TABLE 13 INNOVATIONS AND PATENT REGISTRATIONS, 2020-2024
TABLE 14 GENOMICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 15 GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
TABLE 16 GENOMICS MARKET: IMPACT OF PORTER'S FIVE FORCES
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
TABLE 18 KEY BUYING CRITERIA, BY END USER
TABLE 19 SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
TABLE 20 LONG-READ WHOLE GENOME SEQUENCING WAS USED IN CHILDREN'S MERCY KANSAS CITY
TABLE 21 IMPORT VALUE, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 22 EXPORT VALUE, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 23 IMPORT VOLUME, BY COUNTRY, 2019-2023 (TONS)
TABLE 24 EXPORT VOLUME, BY COUNTRY, 2019-2023 (TONS)
TABLE 25 IMPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017-2021 (USD THOUSAND)
TABLE 26 EXPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017-2021 (USD THOUSAND)
TABLE 27 IMPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (USD THOUSAND)
TABLE 28 IMPORT VOLUME FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (UNITS)
TABLE 29 EXPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (USD THOUSAND)
TABLE 30 EXPORT VOLUME FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (UNITS)
TABLE 31 GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 32 GENOMICS MARKET FOR PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 33 NORTH AMERICA: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 34 EUROPE: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 36 LATIN AMERICA: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 37 MIDDLE EAST: GENOMICS MARKET FOR PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 38 GCC COUNTRIES: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 39 GENOMICS MARKET FOR SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 40 NORTH AMERICA: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 41 EUROPE: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 43 LATIN AMERICA: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 44 MIDDLE EAST: GENOMICS MARKET FOR SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 45 GCC COUNTRIES: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 46 GENOMICS MARKET FOR PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 47 GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 48 NORTH AMERICA: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 49 EUROPE: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 50 ASIA PACIFIC: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 51 LATIN AMERICA: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 52 MIDDLE EAST: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 53 GCC COUNTRIES: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 54 GENOMICS MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 55 NORTH AMERICA: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 56 EUROPE: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 57 ASIA PACIFIC: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 58 LATIN AMERICA: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 59 MIDDLE EAST: GENOMICS MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 60 GCC COUNTRIES: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 61 GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 62 NORTH AMERICA: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 63 EUROPE: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 64 ASIA PACIFIC: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 65 LATIN AMERICA: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 66 MIDDLE EAST: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 67 GCC COUNTRIES: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 68 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 69 GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 70 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 71 EUROPE: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 72 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 73 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 74 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 75 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 76 GENOMICS PRODUCTS MARKET FOR PCR, BY REGION, 2022-2029 (USD MILLION)
TABLE 77 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 78 EUROPE: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 79 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 80 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 81 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PCR, BY REGION, 2022-2029 (USD MILLION)
TABLE 82 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 83 GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY REGION, 2022-2029 (USD MILLION)
TABLE 84 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 85 EUROPE: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 86 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 87 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 88 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY REGION, 2022-2029 (USD MILLION)
TABLE 89 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 90 GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2029 (USD MILLION)
TABLE 91 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 92 EUROPE: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 93 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 94 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 95 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2029 (USD MILLION)
TABLE 96 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 97 GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY REGION, 2022-2029 (USD MILLION)
TABLE 98 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 99 EUROPE: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 100 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 101 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 102 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY REGION, 2022-2029 (USD MILLION)
TABLE 103 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 104 GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 105 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 106 EUROPE: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 107 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 108 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 109 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 110 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 111 GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 112 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 113 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 115 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 116 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 117 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 118 GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 119 GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 120 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 121 EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 123 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 124 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 125 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 126 GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 127 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 128 EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 129 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 130 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 131 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 132 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 133 GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 134 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 135 EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 137 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 138 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 139 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 140 GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2022-2029 (USD MILLION)
TABLE 141 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 142 EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 143 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 144 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 145 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2022-2029 (USD MILLION)
TABLE 146 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 147 GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 148 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 149 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 151 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 152 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 153 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 154 GENOMICS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 155 GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 156 NORTH AMERICA: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 157 EUROPE: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 158 ASIA PACIFIC: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 159 LATIN AMERICA: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 160 MIDDLE EAST: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 161 GCC COUNTRIES: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 162 GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 163 NORTH AMERICA: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 164 EUROPE: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 165 ASIA PACIFIC: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 166 LATIN AMERICA: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 167 MIDDLE EAST: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 168 GCC COUNTRIES: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 169 GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 170 NORTH AMERICA: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 171 EUROPE: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 172 ASIA PACIFIC: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 173 LATIN AMERICA: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 174 MIDDLE EAST: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 175 GCC COUNTRIES: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 176 GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 177 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
TABLE 178 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 179 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 180 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 181 LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 182 MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
TABLE 183 GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 184 GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 185 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 186 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 187 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 188 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 189 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION )
TABLE 190 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 191 GENOMICS MARKET FOR DIAGNOSTICS APPLICATION, BY TYPE, 2022-2029 (USD MILLION)
TABLE 192 GRANTS, BY CANCER TYPE (AS OF JANUARY 2023)
TABLE 193 ONCOLOGY: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 194 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 195 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 196 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 197 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 198 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY REGION, 2022-2029 (USD MILLION)
TABLE 199 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 200 INFECTIOUS DISEASES: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 201 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 202 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 204 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 205 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY REGION, 2022-2029 (USD MILLION)
TABLE 206 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 207 REPRODUCTIVE HEALTH: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 208 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 209 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 210 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 211 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 212 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY REGION, 2022-2029 (USD MILLION)
TABLE 213 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 214 GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 215 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 216 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 217 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 218 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 219 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 220 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 221 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 222 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 223 EUROPE: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 225 LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 226 MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 227 GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 228 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 229 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 230 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 232 LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 233 MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 234 GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 235 GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 236 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 237 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 238 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 239 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 240 LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 241 MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 242 GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 243 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2022-2029 (USD MILLION)
TABLE 244 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 245 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 246 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 247 LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 248 MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2022-2029 (USD MILLION)
TABLE 249 GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 250 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
TABLE 251 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 252 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 253 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 254 LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 255 MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
TABLE 256 GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 257 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 258 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 259 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 260 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 261 LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 262 MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 263 GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 264 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2022-2029 (USD MILLION)
TABLE 265 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 266 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 267 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 268 LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 269 MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2022-2029 (USD MILLION)
TABLE 270 GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 271 GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 272 GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 273 NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 274 EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 275 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 276 LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 277 MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 278 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 279 GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 280 NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 281 EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 282 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 283 LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 284 MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 285 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 286 GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 287 NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 288 EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 289 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 290 LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 291 MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 292 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 293 GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 294 NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 295 EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 296 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 297 LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 298 MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 299 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 300 GENOMICS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 301 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 302 NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 303 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 304 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 305 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 306 NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 307 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 308 NORTH AMERICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 309 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 310 NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 311 NORTH AMERICA: KEY MACROINDICATORS
TABLE 312 US: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 313 US: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 314 US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 315 US: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 316 US: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 317 US: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 318 US: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 319 US: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 320 US: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 321 CANADA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 322 CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 323 CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 324 CANADA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 325 CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 326 CANADA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 327 CANADA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 328 CANADA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 329 CANADA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 330 EUROPE: GENOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 331 EUROPE: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 332 EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 333 EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 334 EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 335 EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 336 EUROPE: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 337 EUROPE: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 338 EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 339 EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 340 EUROPE: KEY MACROINDICATORS
TABLE 341 GERMANY: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 342 GERMANY: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 343 GERMANY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 344 GERMANY: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 345 GERMANY: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 346 GERMANY: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 347 GERMANY: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 348 GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 349 GERMANY: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 350 UK: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 351 UK: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 352 UK: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 353 UK: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 354 UK: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 355 UK: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 356 UK: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 357 UK: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 358 UK: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 359 FRANCE: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 360 FRANCE: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 361 FRANCE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 362 FRANCE: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 363 FRANCE: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 364 FRANCE: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 365 FRANCE: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 366 FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 367 FRANCE: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 368 ITALY: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 369 ITALY: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 370 ITALY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 371 ITALY: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 372 ITALY: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 373 ITALY: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 374 ITALY: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 375 ITALY: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 376 ITALY: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 377 SPAIN: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 378 SPAIN: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 379 SPAIN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 380 SPAIN: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 381 SPAIN: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 382 SPAIN: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 383 SPAIN: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 384 SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 385 SPAIN: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 386 REST OF EUROPE: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 387 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 388 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 389 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 390 REST OF EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 391 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 392 REST OF EUROPE: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 393 REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 394 REST OF EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 395 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 396 ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 397 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 398 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 399 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 400 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 401 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 402 ASIA PACIFIC: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 403 ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 404 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 405 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 406 CHINA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 407 CHINA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 408 CHINA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 409 CHINA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 410 CHINA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 411 CHINA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 412 CHINA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 413 CHINA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 414 CHINA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 415 JAPAN: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 416 JAPAN: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 417 JAPAN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 418 JAPAN: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 419 JAPAN: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 420 JAPAN: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 421 JAPAN: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 422 JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 423 JAPAN: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 424 INDIA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 425 INDIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 426 INDIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 427 INDIA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 428 INDIA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 429 INDIA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 430 INDIA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 431 INDIA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 432 INDIA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 433 AUSTRALIA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 434 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 435 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 436 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 437 AUSTRALIA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 438 AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 439 AUSTRALIA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 440 AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 441 AUSTRALIA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 442 SOUTH KOREA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 443 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 444 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 445 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 446 SOUTH KOREA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 447 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 448 SOUTH KOREA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 449 SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 450 SOUTH KOREA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 451 REST OF ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 452 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 453 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 454 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 455 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 456 REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 457 REST OF ASIA PACIFIC: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 458 REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 459 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 460 LATIN AMERICA: GENOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 461 LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 462 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 463 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 464 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 465 LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 466 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 467 LATIN AMERICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 468 LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 469 LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 470 LATIN AMERICA: KEY MACROINDICATORS
TABLE 471 BRAZIL: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 472 BRAZIL: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 473 BRAZIL: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 474 BRAZIL: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 475 BRAZIL: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 476 BRAZIL: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 477 BRAZIL: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 478 BRAZIL: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 479 BRAZIL: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 480 MEXICO: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 481 MEXICO: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 482 MEXICO: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 483 MEXICO: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 484 MEXICO: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 485 MEXICO: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 486 MEXICO: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 487 MEXICO: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 488 MEXICO: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 489 REST OF LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 490 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 491 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 492 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 493 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 494 REST OF LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 495 REST OF LATIN AMERICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 496 REST OF LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 497 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 498 MIDDLE EAST: GENOMICS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 499 MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 500 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 501 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 502 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 503 MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 504 MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 505 MIDDLE EAST: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 506 MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 507 MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 508 MIDDLE EAST: KEY MACROINDICATORS
TABLE 509 GCC COUNTRIES: GENOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 510 GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 511 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 512 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 513 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 514 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 515 GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 516 GCC COUNTRIES: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 517 GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 518 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 519 SAUDI ARABIA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 520 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 521 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 522 SAUDI ARABIA: GENOMICS PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 523 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 524 SAUDI ARABIA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 525 SAUDI ARABIA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 526 SAUDI ARABIA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 527 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 528 UNITED ARAB EMIRATES: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 529 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 530 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 531 UNITED ARAB EMIRATES: GENOMICS PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 532 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 533 UNITED ARAB EMIRATES: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 534 UNITED ARAB EMIRATES: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 535 UNITED ARAB EMIRATES: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 536 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 537 REST OF GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 538 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 539 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 540 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 541 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 542 REST OF GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 543 REST OF GCC COUNTRIES: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 544 REST OF GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 545 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 546 REST OF MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 547 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 548 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 549 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 550 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 551 REST OF MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 552 REST OF MIDDLE EAST: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 553 REST OF MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 554 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 555 AFRICA: GENOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 556 AFRICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 557 AFRICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 558 AFRICA: GENOMICS PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 559 AFRICA: GENOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 560 AFRICA: GENOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 561 AFRICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022-2029 (USD MILLION)
TABLE 562 AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2022-2029 (USD MILLION)
TABLE 563 AFRICA: GENOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 564 MACROECONOMIC OUTLOOK FOR GENOMICS MARKET IN AFRICA
TABLE 565 OVERVIEW OF STRATEGIES ADOPTED BY KEY GENOMICS COMPANIES
TABLE 566 GENOMICS MARKET: DEGREE OF COMPETITION
TABLE 567 GENOMICS MARKET: REGIONAL FOOTPRINT
TABLE 568 GENOMICS MARKET: OFFERING FOOTPRINT, BY PRODUCT TYPE
TABLE 569 GENOMICS MARKET: APPLICATION FOOTPRINT
TABLE 570 GENOMICS MARKET: TECHNOLOGY FOOTPRINT
TABLE 571 GENOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 572 GENOMICS MARKET: COMPANY FOOTPRINT (STARTUPS/SMES)
TABLE 573 GENOMICS MARKET: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 574 GENOMICS MARKET: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 575 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 576 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 577 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 578 ILLUMINA, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 579 ILLUMINA, INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 580 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 581 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 582 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-SEPTEMBER 2024
TABLE 583 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 584 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021- SEPTEMBER 2024
TABLE 585 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 586 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 587 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2021- SEPTEMBER 2024
TABLE 588 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 589 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 590 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 591 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021- SEPTEMBER 2024
TABLE 592 DANAHER CORPORATION: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 593 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 594 QIAGEN: COMPANY OVERVIEW
TABLE 595 QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 596 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 597 QIAGEN: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 598 QIAGEN: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 599 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 600 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 601 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 602 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 603 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 604 REVVITY: COMPANY OVERVIEW
TABLE 605 REVVITY: PRODUCTS/SERVICES OFFERED
TABLE 606 REVVITY: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 607 REVVITY: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 608 REVVITY: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 609 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
TABLE 610 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
TABLE 611 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 612 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 613 IQVIA INC.: COMPANY OVERVIEW
TABLE 614 IQVIA INC.: SERVICES OFFERED
TABLE 615 IQVIA INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 616 IQVIA INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 617 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
TABLE 618 CHARLES RIVER LABORATORIES: SERVICES OFFERED
TABLE 619 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 620 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 621 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 622 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021- SEPTEMBER 2024
TABLE 623 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 624 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 625 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 626 EUROFINS SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 627 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 628 PACBIO: COMPANY OVERVIEW
TABLE 629 PACBIO: PRODUCTS/SERVICES OFFERED
TABLE 630 PACBIO: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 631 PACBIO: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 632 PACBIO: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 633 PACBIO: OTHER DEVELOPMENTS, JANUARY 2021-SEPTEMBER 2024
TABLE 634 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW
TABLE 635 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCTS/SERVICES OFFERED
TABLE 636 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 637 OXFORD NANOPORE TECHNOLOGIES PLC.: DEALS, JANUARY 2021- SEPTEMBER 2024
TABLE 638 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 639 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
TABLE 640 TAKARA BIO INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021- SEPTEMBER 2024
TABLE 641 TAKARA BIO INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 642 BGI GROUP: COMPANY OVERVIEW
TABLE 643 BGI GROUP: PRODUCTS/SERVICES OFFERED
TABLE 644 BGI GROUP: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 645 BGI GROUP: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 646 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2021-SEPTEMBER 2024
TABLE 647 EPPENDORF SE: COMPANY OVERVIEW
TABLE 648 EPPENDORF SE: PRODUCTS/SERVICES OFFERED
TABLE 649 EPPENDORF SE: PRODUCT & SERVICE LAUNCHES, JANUARY 2021- SEPTEMBER 2024
TABLE 650 MERCK KGAA: COMPANY OVERVIEW
TABLE 651 MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 652 MERCK KGAA: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
TABLE 653 BD: COMPANY OVERVIEW
TABLE 654 BD: PRODUCTS/SERVICES OFFERED
TABLE 655 BD: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 656 BD: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 657 ABBOTT: COMPANY OVERVIEW
TABLE 658 ABBOTT: PRODUCTS/SERVICES OFFERED
TABLE 659 ABBOTT: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 660 10X GENOMICS: COMPANY OVERVIEW
TABLE 661 10X GENOMICS: PRODUCTS/SERVICES OFFERED
TABLE 662 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 663 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
TABLE 664 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
TABLE 665 NEW ENGLAND BIOLABS: PRODUCT & SERVICE LAUNCHES, JANUARY 2021- SEPTEMBER 2024
TABLE 666 NEW ENGLAND BIOLABS: DEALS, JANUARY 2021-SEPTEMBER 2024
TABLE 667 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 668 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 669 PROMEGA CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
TABLE 670 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021- SEPTEMBER 2024
TABLE 671 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024

List of Figures

FIGURE 1 RESEARCH DESIGN
FIGURE 2 GENOMICS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 3 GENOMICS PRODUCTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF AGILENT TECHNOLOGIES, INC. (2023)
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 8 GENOMICS PRODUCTS MARKET: CAGR PROJECTIONS
FIGURE 9 DATA TRIANGULATION
FIGURE 10 GENOMICS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 11 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
FIGURE 12 GENOMICS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 GENOMICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 GENOMICS MARKET, BY STUDY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 15 GENOMICS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 GEOGRAPHIC ANALYSIS: GENOMICS MARKET
FIGURE 17 TECHNOLOGICAL ADVANCEMENTS IN GENOME SEQUENCING DRIVING MARKET GROWTH
FIGURE 18 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF GENOMICS MARKET IN ASIA PACIFIC IN 2023
FIGURE 19 CHINA LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL GENOMICS MARKET DURING FORECAST PERIOD
FIGURE 20 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 21 GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 BURDEN OF HIV INFECTIONS, BY REGION, 2023
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN GENOMICS MARKET
FIGURE 24 GENOMICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN OF GENOMICS WORKFLOW: SEQUENCING & ANALYSIS ADD MAXIMUM VALUE TO WORKFLOW
FIGURE 26 AVERAGE SELLING PRICE TREND, BY INSTRUMENT, 2021-2023 (USD)
FIGURE 27 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021-2023 (USD)
FIGURE 28 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD)
FIGURE 29 INDICATIVE PRICE TREND OF INSTRUMENTS, BY REGION, 2021-2023 (USD)
FIGURE 30 PATENT ANALYSIS FOR GENOMICS MARKET, 2014-2024
FIGURE 31 GENOMICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 32 GENOMICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 33 PORTER'S FIVE FORCES ANALYSIS OF GENOMICS MARKET
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 35 KEY BUYING CRITERIA, BY END USER
FIGURE 36 RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS, 2018-2024 (USD MILLION)
FIGURE 37 IMPACT OF AI/GEN AI ON GENOMICS MARKET
FIGURE 38 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
FIGURE 39 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN GENOMICS MARKET, 2019-2023 (USD MILLION)
FIGURE 41 GENOMICS PRODUCT MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
FIGURE 42 GENOMICS SERVICES MARKET RANK, BY KEY PLAYERS (2023)
FIGURE 43 BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 44 GENOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 45 GENOMICS MARKET: COMPANY FOOTPRINT
FIGURE 46 GENOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 47 EV/EBITDA OF KEY VENDORS
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 49 ILLUMINA, INC.: COMPANY SNAPSHOT (2023)
FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
FIGURE 52 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 53 QIAGEN: COMPANY SNAPSHOT (2023)
FIGURE 54 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 55 REVVITY: COMPANY SNAPSHOT (2023)
FIGURE 56 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023)
FIGURE 57 IQVIA INC.: COMPANY SNAPSHOT (2023)
FIGURE 58 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023)
FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 60 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
FIGURE 61 PACBIO: COMPANY SNAPSHOT (2023)
FIGURE 62 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT (2023)
FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
FIGURE 64 EPPENDORF SE: COMPANY SNAPSHOT (2023)
FIGURE 65 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 66 BD: COMPANY SNAPSHOT (2023)
FIGURE 67 ABBOTT: COMPANY SNAPSHOT (2023)
FIGURE 68 10X GENOMICS: COMPANY SNAPSHOT (2023)